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ABSTRACT
Introduction: Preeclampsia is characterised by the increased 
excretion of misfolding protein, attracted by a Diazo dye 
denominated congo red. 
Aim: To compare congo red staining kit versus a urocolor test to 
determine proteinuria in patients with preeclampsia. 
Materials and Methods: This was a prospective, transversal 
study, performed between August 2010 to July 2011, including 
pregnant and puerperal women with the clinical diagnosis of 
preeclampsia. From all patients, a single sample of 24 hours 
urine was tested with congo red to determine the presence 
of proteinuria, comparing the qualitative results of the urine 
dipstick for proteinuria and the gold standard determination of 
protein in 24 hours urine collection. Differences among nominal 
conditions were evaluated by the Mann-Whitney U-test.
Results: A total of 50 pregnant and puerperal women were 
included in this study. The statistical comparison between 2 vs. 
3, 2 vs. 4 and 3 vs. 4, congo red positive fields reached significant 
difference (p≤0.001) in relation to the mean proteinuria values 
for each one. In contrast, with the urocolor test there were no 
differences per number of positive crosses. 
Conclusion: The congo red has a high selectivity for beta-
folded proteins in preeclampsia being a promising screening 
test of high value to the clinician.
INTRODUCTION
During pregnancy, protein excretion is increased due to a decrease 
in the proximal tubule reabsorption of Low-Molecular-Weight 
(LMW) proteins filtered by the glomerulus. Importantly, even healthy 
pregnant women can register proteinuria of >300 mg/dL [1].
Quantification of proteinuria in a 24 hours urine sample is mandatory 
in the comprehensive assessment of women with hypertensive 
disorders during pregnancy and, in some cases, it is necessary to 
establish the diagnosis of preeclampsia and its severity [2,3].
Significant proteinuria is defined by the National High Blood Pressure 
Education Program (NHBPEP) working group as an excretion of 
>300 mg of protein in a 24 hours urine sample. The same working 
group also states that proteinuria of 2 gm/day or greater involves 
increased disease severity, and this figure is set as a criterion for 
defining severe preeclampsia [4]. In contrast, the American College 
of Obstetrics and Gynaecology (ACOG) establishes a proteinuria of 
5 gm/day or more for the diagnosis of severe preeclampsia [5].
Quantification of protein in a 24 hours urine collection is considered 
the gold standard for determining the presence of significant 
proteinuria in pregnancy [6]. However, the collection of urine every 
24 hours is uncomfortable for the patient, time-consuming, and is 
subject to errors due to inadequate collection, delays the diagnosis 
for at least 24 hours, and it has been reported that fewer than one 
half of the sick women hospitalised with diagnosis of preeclampsia 
have a 24 hours urine collection. Due to the disadvantage of 
collecting 24 hours urine, other options have been proposed for the 
diagnosis of significant proteinuria in pregnancy. These other tests 
are fast and reliable, for example, the use of labstix or a test strip, 
measurement of proteinuria in short periods of urine collection, and 
the protein/urine creatinine ratio [7-9].
Protein three-dimensional conformation is the result of unfolded 
polypeptides that goes through a molecular folding process 
for which several models have been proposed. The misfolded 
proteins produce amorphous aggregation, a phenomenon 
determined by the melting temperature (Tm) [10]. Some protein 
misfolding diseases include Alzheimer’s, Parkinson’s and some 
neurodegenerative diseases [11]. Interestingly, preeclampsia is 
characterised by the increased excretion of misfolding protein, 
attracted by a Diazo dye enominated congo red [12]. By using 
an unbiased mass spectrometry proteomic profiling approach, the 
group of Buhimschi IA et al., discovered that urine of women with 
severe preeclampsia displayed a characteristic set of proteomic 
biomarkers consisting of nonrandom proteoforms of SERPINA1 
and albumin [13]. SERPINA1 fragments have the propensity 
to misfold and aggregate into supramolecular structures [14], 
thus showing congophilia, a characteristic of protein misfolding 
[15]. The aim of this study was to compare congo red staining 
kit versus a urocolor test to determine proteinuria in patients 
with preeclampsia, looking for a more specific option with good 
correlation to the 24 hours urine collection test.
MATERIALS AND METHODS
This was a prospective, descriptive, cross-sectional, pilot study 
conducted at the “Mónica Pretelini Sáenz” Maternal-Perinatal 
Hospital (HMPMPS), Health Institute of the State of Mexico 
(ISEM), Toluca from August 2010 to July 2011. The sample was 
set with a convenience non-probability sampling, based on the 
congo red tests available. Fifty pregnant women with >20 and <41 
weeks gestation or in immediate puerperium exhibiting the clinical 
criteria of preeclampsia were enrolled in the study. The diagnosis 
of preeclampsia was consistent with the recommendations of the 
ACOG [5]. Women with a history of preeclampsia, Urinary Tract 
Infection (UTI), kidney disease, or gestational hypertension were 
excluded from the study. Patients with incomplete medical files were 
discarded from the final analysis. The present study was approved 
by the Ethics Committee of the HMPMPS (Code: EI/136) and was 
conducted in accordance with the Helsinki Declaration (Fortaleza, 
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Brazil). Written informed consent was obtained from all patients who 
participated in the study.
General Information
The primary source of information was collected through the review 
of medical records and taking into account the following: age; 
educational level; factors associated with a gestational hypertensive 
disorder; number of sexual partners; prenatal care; type of delivery 
of the infant; main indication for cesarean section, and maternal and 
perinatal outcomes.
Congo Red
The Highman’s method was adjusted using the semiquantitative 
Congo Red Kit (catalogue #101641; Merck Millipore, USA) [16]. The 
Congo red staining principle is based on the formation of hydrogen 
bridge bonds with the carbohydrate component of the substrate. 
Congo red is an anionic dye and is capable of depositing itself in 
amyloid fibrils, which then exhibit a conspicuous dichroism under 
polarised light. The tissue stained with Congo red appears orange-
red under the transmitted-light microscope; under polarised light; 
however, the amyloid deposits show up as brilliant green double-
refraction images against a dark background. The staining process 
was conducted by the Clinical Laboratory Service, taking an 
average of 12 minutes. The reading was performed by two chemical 
pharmacobiologists and an expert in anatomopathology. Each slide 
was divided in four visual fields at the moment of the microscopic 
visualisation to give a report based on the positive quadrants (fields).
Process
In Highman’s method, the staining was done with an alcoholic 
solution (in present case 2% isopropyl alcohol was used), followed 
by a differentiation with an alkaline solution (KOH). In the present 
process the urinary sediment was used as a specimen to study and 
therefore steps of the process were minimised.
The sample was collected after a centrifugation for 3 minutes, and 
then it was fixed with heat. The next step was staining in congo 
red solution, followed by rinsing and drying. The interpretation was 
estimating its presence and the distribution in fields (quadrants) of 
vision in the microscope [Table/Fig-1]. It was reported as a positive 
result to dark blue nuclei whose center (amyloid) was pink-red 
pigmented and the periphery metachromasia green when using 
polarised light. Simultaneously, the 24 hours urine collection, and 
two measurements with urocolor 11 test strips within the first 6 
hours, using a chromatic scale were also performed.
normality hypothesis was tested using the Kolmogorov-Smirnov test. 
Differences among nominal conditions were evaluated by the Mann-
Whitney U-test. The intra and interobserver Kappa index were calculated 
for the identification of positive congophilia. In all cases, p≤0.05 was 
considered statistically significant. All tests were performed with the 
SPSS version 23.0 statistical software program (IBM SPPS 23, USA).
RESULTS
General Characteristics
Considering 436 hospital admissions (0.88 admissions/day) into 
the Obstetrics Intensive Care Unit (OICU) during the study frame 
time, preeclampsia represented a total of 223 cases (51.14%) (0.44 
admissions/day). From all this population only 50 women were 
selected. Mean age was 27.4±7.2 years, with an average hospital 
stay of 3.6±1.5 days and with three organ dysfunctions. The [Table/
Fig-2] shows the general characteristics of the studied population.
[Table/Fig-1]: Exemplification of the microscopic slide division in quadrants.
variable value
Age (years) 27.4±7.2
Gestational age (weeks) 33.96±2.5
Mean arterial pressure (mmHg) 111.6±24.3
Proteinuria (mg/dL) 3076.2±1677.6
Stay in the obstetrical ICU (days) 3.6±1.5
[Table/Fig-2]: General characteristics of the patients. 
ICU: Intensive care unit
Age range (Years) n (Percentage)
15-20 9 (18%)
21-25 12 (24%)
26-30 14 (28%)
31-35 6 (12%)
36-40 7 (14%)
≥40 years 2 (4%)
Total 50 (100%)
[Table/Fig-3]: Distribution of patients per age range.
Organ failure n (Percentage)
Renal 50 (100%)
Haematological 31 (62%)
Hepatic 29 (58%)
Cardiovascular 28 (56%)
Neurological 13 (26%)
Respiratory dysfunction 7 (14%)
[Table/Fig-4]: Main organ dysfunctions.
Outcome unit
APGAR score at 5 minutes (mean±SD) 7.4±1.8
Fetal weight (gm) (mean±SD) 1951.9±742.5
Intrauterine growth restriction (cases) 12 (24%)
Cesarean section (cases) 44 (88%)
[Table/Fig-5]: Fetal outcomes. 
SD: Standard deviation
In relation to the obstetrical data, 1 (28%) were primiparous and the 
average number of pregnancies was 2.72. Women were found at an 
obstetric gestational age of 33.96 weeks (early preeclampsia) and 
45 (90%) had risk factors. The [Table/Fig-3] shows the distribution 
by age. Analysis of organ dysfunction was based on the Sequential 
Organ Failure Assessment (SOFA) classification and the main organ 
dysfunctions are described in [Table/Fig-4] [17]. At the moment of 
hospital discharge, >96% of patients had experienced remission of 
all dysfunctions. 26 (52%) of all women had fetal compromise. Fetal 
outcomes are described in [Table/Fig-5]. 
STATISTICAL ANALYSIS
Quantitative variables were expressed as mean±Standard Deviation 
(SD) and qualitative variables in frequency and percentage. The 
www.jcdr.net JL Rodríguez Chávez et al., Congo Red Staining in Preeclampsia
Journal of Clinical and Diagnostic Research. 2018 May, Vol-12(5): QM01-QM05 3
Congo Red
Congophilia was present in two fields in 12 (24%), in three fields 
34% (n=17), and in four fields, in 21 (42%). The intraobserver Kappa 
index was 0.87 (expected, 0.5) and the interobserver Kappa index 
was 0.740 {Standard Error (SE): 0.067; 95% Confidence Interval 
(95% CI), 0608-0872}.
In the whole population mean proteinuria value was 3,076.2 mg. In 4 
(8%) protein determination was <1,000 mg, while in 10 (20%) this fell 
within the range of 1,001-2,000, 12 (24%) within the range of 2,001-
3,000 mg, 15 (30%) within the nephrotic range between 3,001 and 
4,000 mg, 4 (8%) exhibited between 4,001 and 5,000 mg and over 
5,000 mg, 5 (10%). Visualising this information. The [Table/Fig-6] 
shows the mean proteinuria values per number of positive congo red 
fields and displays the information for urocolor 11 test strips [Table/
Fig-7]. Contrastingly, although that 100% of cases were positive for 
congo red test none was 4+ positive in the urocolor 11 strip despite 
signs of nephrotic-range proteinuria [Table/Fig-8]. 
Kolmogorov-Smirnov normality test was used and evidenced a 
non-Gaussian distribution for proteinuria per group of red congo 
positive identification. In view of the results, Mann-Whitney U-test 
was used to compare the proteinuria values [Table/Fig-9].
On the other hand, the mean proteinuria values per number of 
crosses in the urocolor strip are shown in [Table/Fig-10]. Immediately 
stands out the fact that the proteinuria did not increase in relation to 
the crosses and the comparison was not significant [Table/Fig-11].
Congo red 
fields 
n Mean
Standard 
deviation
error
95% Confidence interval 
for the mean Minimum Maximum
Lower limit upper limit
2 12 1366.4 375.0 108.2 1128.0 1604.7 934.2 1892.0
3 17 2664.5 471.0 114.2 2422.3 2906.7 1490.0 3349.7
4 21 4386.7 1714.3 374.0 3606.3 5167.0 2763.1 9967.1
Total 50 3076.2 1677.6 237.2 2599.5 3553.0 934.2 9967.1
[Table/Fig-6]: Proteinuria values per number of congo red positive fields.
Congo red  
positive 
fields
urocolor 11 strip positive crosses
total
none One two three
2 6 6 0 0 12
3 9 5 2 1 17
4 6 12 3 0 21
Total 21 23 5 1 50
[Table/Fig-7]: Number of urocolor positive crosses per congo red positive fields.
Case
Positive congo 
red fields in the 
 microscope slides
urolabstix Proteinuria in 
24 hours urine 
 collection (mg)1+ 2+ 3+ 4+
1 3 0 0 0 0 2865
2 2 0 0 0 0 1765
3 3 0 0 0 0 2716
4 2 0 0 0 0 958.4
5 2 1 0 0 0 1892
6 3 0 0 0 0 2789
7 4 0 0 0 0 3209
8 4 1 0 0 0 9967.1
9 2 0 0 0 0 1243.6
10 3 0 0 0 0 2345.7
11 4 1 0 0 0 3522.2
12 3 0 0 0 0 2891
13 2 1 0 0 0 934.2
14 4 0 0 0 0 6540
15 3 1 0 0 0 3240
16 4 0 1 0 0 3819
17 3 0 1 0 0 2782
18 4 1 0 0 0 3276
19 4 0 1 0 0 3202.1
20 4 1 0 0 0 3298.1
21 3 0 0 1 0 2952.4
22 2 0 0 0 0 1856
23 4 1 0 0 0 4563.2
24 4 0 1 0 0 3248.5
25 4 1 0 0 0 2763.1
26 3 0 1 0 0 2840.2
27 4 1 0 0 0 3329
28 2 1 0 0 0 1455.3
29 3 1 0 0 0 3345.3
30 4 1 0 0 0 4356.2
31 3 1 0 0 0 2314.6
32 2 1 0 0 0 1356
33 4 1 0 0 0 6577
34 3 1 0 0 0 2344
35 4 0 0 0 0 4562
36 4 1 0 0 0 3325
37 2 1 0 0 0 980
38 2 1 0 0 0 1778
39 4 1 0 0 0 3459
40 4 1 0 0 0 4356
41 4 0 0 0 0 5890
42 3 1 0 0 0 2347.9
43 4 0 0 0 0 3298
44 4 0 0 0 0 5560.2
45 3 0 0 0 0 1490
46 3 0 0 0 0 2210.1
47 2 0 0 0 0 1198.1
48 2 0 0 0 0 980.2
49 3 0 0 0 0 3349.7
50 3 0 0 0 0 2474
[Table/Fig-8]: Congo red positive fields, urocolor test and proteinuria in 24 hours 
urine collection.
Groups of comparison per 
congo red positive fields
Mann-Whitney  
u-test
W of 
 Wilcoxon
z Sig.
2 vs. 3 4 82 -4.34 ≤0.001
2 vs. 4 0.0 78 -4.715 ≤0.001
3 vs. 4 27 180 -4.448 ≤0.001
[Table/Fig-9]: Comparison of proteinuria per congo red positive fields.
Sig: Significance
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DISCUSSION
As noted, the percentage of caesarean sections exceeded the 
expected international goals, with 44 cases (88%). This is a national 
trend that has been widely discussed [18,19].
Today, many hospitals include the use of urine dipstick in the 
comprehensive evaluation of women with hypertensive disorders 
of pregnancy because it comprises part of international criteria 
for preeclampsia [20,21]. The urine dipstick is inexpensive and 
easy to use, and the result of the application of this resource is 
that it determines an approximate protein concentration, but not 
an absolute value. The patient’s hydration status can influence the 
result; in fact, a false-negative result may occur in urine samples with 
a density of <1.010, or in the presence of high salt concentrations, 
with a very acidic proteinuria pH or proteinuria not due to the 
presence of albumin. All of these factors render the urine dipstick 
poorly correlated with the 24 hours proteinuria determination, 
leading to a low diagnostic performance as an indicator of 
significant proteinuria [22]. The analysis of several studies that 
have investigated the reliability of the urine dipstick have found low 
sensitivity and specificity, resulting in a diagnosis of preeclampsia that 
is poorly sustained or underdiagnosed [23,24]. This last sentence is 
accordance with our results as in some severe cases of proteinuria, 
identified both by 24 hours urine collection and congo red, the urine 
dipstick was negative. Therefore, with the urocolor strip there was 
poor association with disease severity ranges.
Although, determination of proteinuria by dipstick is deficient 
compared with the proteinuria value in the 24 hours urine sample 
[25], it is widely used. Even more, the absence of proteinuria on 
dipstick testing may have ruled out the presence of significant 
proteinuria in patients. Another alternative for the presence-of-
proteinuria feature has been collecting urine for short periods 
(8 or 12 hours), which shares limitations and problems with the 
collection of 24 hours urine [26]. In this current manuscript, 38% 
of the patients had proteinuria ≥3 gm/dL, illustrating the severity 
of present cases.
In a pilot study based on the congophilia test in urine, Buhimschi IA 
et al., found that 4/35 (11%) of asymptomatic women were positive 
for congo red prior to the development of preeclampsia [12]. These 
findings indicate the possibility of developing a test to predict and 
diagnose preeclampsia that only requires a few drops of urine, 
according to the author.
A previous study revealed a Detection Rate (DR) of 93% and a 
False-Positive Rate (FPR) of 4%. However, with first-trimester urine 
samples, DR was 33.3, 16.1, and 20% for early, late, and all cases 
of preeclampsia, respectively, with a 12.8% FPR. The Odds Ratio 
(OR) for preeclampsia was superior to Body Mass Index (BMI), 
and Mean Arterial Blood Pressure (MAP), but inferior to previous 
preeclampsia and black ethnicity. In the first trimester, the Congo 
Red urine test adds accuracy for preeclampsia prediction in obese, 
black women who had previous preeclampsia and above-average 
mean arterial pressure [27].
In the present pilot study, the positivity with congo red was 100%, but 
we have to be aware that the observed variability in the positive fields 
is an issue that can be used for quality and interobserver analysis.
Recently, Parikh L et al., in a study with 101 women over 14 weeks 
gestation undergoing evaluation for preeclampsia and diabetes 
proved that the Congo Red Retention (CRR) was not increased 
in diabetic gravidas without preeclampsia even in the presence 
of baseline nephropathy. They also determined that a CRR over 
15% correctly classified all women with preeclampsia and adverse 
pregnancy outcomes [28].
It is clear from this study that there is an increase in proteinuria 
values, with the Congo Red staining from two to three positive 
fields in 1298.1 mg and 1722.2 mg from three to four positive 
fields. Furthermore, the statistical comparison between 2 vs. 3, 2 
vs. 4 and 3 vs. 4 congo red positive fields at the microscope slide 
visualisation reached significant difference (p≤0.001) en relation 
to the mean proteinuria values for each one, contrasting with the 
lack of significance with the urocolor test, an expected result due 
to the heterogeneous proteinuria increase per number of positive 
crosses in the strip. 
The cost of the congo red it is an important issue. Although, it is 
more expensive than the urocolor tests available in the market, 
as one can infer from the statistical analysis, the second option 
does not offer congruent data with the proteinuria values, thus 
putting patients at risk of a misdiagnosis and incorrect treatment. 
A handicap of the CRR is that this technique might not be able to 
differentiate between autoimmune diseases like lupus nephritis and 
a hypertensive disorder of pregnancy, and this condition applies for 
other kits available in the market [29-31]. 
Preeclampsia is still one of leading causes of maternal mortality 
worldwide; unfortunately, reliable and economically affordable 
biomarkers to predict it are elusive [32]. Herein, combining 
biomarkers may improve the prediction of pregnancy hypertension 
in the early stages of gestation and we believe CRR could add to the 
positive predictive value of a set of tests to diagnose preeclampsia 
at an early stage [33].
Despite the difficulty to explore the congophilia with the selected 
kit, the results lead us to think about the possibility of designing a 
kit or a test strip using congo red to determine proteinuria at low 
cost, using it at home and facilitate the early detection of a possible 
obstetric complication. In fact, Jonas SM et al., have developed a 
smart phone-based diagnostic for preeclampsia administering congo 
red [34]. Further research is required to explore the use of congophilia 
as a common diagnosis test of proteinuria in pregnancy.
number of 
crosses 
n Mean
Standard 
deviation
error
95% Confidence interval 
for the mean Minimum Maximum
Lower limit upper limit
none 21 2866.2 1595.8 348.2 2139.8 3592.6 958.4 6540.0
1 23 3251.2 1960.7 408.8 2403.3 4099.1 934.2 9967.1
2 5 3178.3 414.5 185.3 2663.6 3693.0 2782.0 3819.0
3 1 2952.4 . . . . 2952.4 2952.4
Total 50 3076.2 1677.6 237.2 2599.5 3553.0 934.2 9967.1
[Table/Fig-10]: Mean proteinuria values per number of crosses in the Urocolor strip.
Groups of comparison per 
urocolor positive crosses
Mann-Whitney 
u-test
W of 
 Wilcoxon
z Sig.
None vs. 1 203 434 -0.905 0.366
None vs. 2 36 267 1.073 0.283
None vs. 3 7 238 -0.552 0.581
1 vs. 2 56 332 -0.090 0.928
1 vs. 3 10 11 -0.217 0.828
2 vs. 3 2 3 -0.293 0.770
[Table/Fig-11]: Comparison of proteinuria per urocolor positive crosses.
Sig: Significance
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LIMITATION
A clear limitation of this study is that it was not a randomised study; 
also, a safety matter of concern is that the congo red stain might 
be carcinogenic. Finally, a second step to contrast this test with a 
control group and different techniques to quantify proteinuria was 
not possible to perform as the used kit was discarded from the 
Mexican market.
CONCLUSION
This study confirms that women with preeclampsia and chronic 
kidney disease without preeclampsia have elevated congophilia 
urine levels. In this regard, the CRR interpreted a positive fields in 
the slide which shows a direct relationship with the proteinuria levels. 
Thus, the congo red test point represents a new diagnostic tool for 
the clinician working in the obstetrics area, who are looking for a 
quick and highly reliable test. This is a test that can be performed 
in any context, even in third-world countries, and the results after 
10-15 minutes are obtained. In summary, the overall assessment 
of the misfolded protein load by congo red staining is expected to 
be a simple, efficient and highly reproducible diagnostic test. The 
results are very encouraging to continue a new line of research. By 
contrast, the urocolor test is not reliable to make a decision for renal 
injury in pregnancy/puerperium.
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